Published in Shock on February 01, 2005
The peroxynitrite catalyst WW-85 improves pulmonary function in ovine septic shock. Shock (2011) 0.89
The peroxynitrite catalyst WW-85 improves microcirculation in ovine smoke inhalation injury and septic shock. Burns (2011) 0.80
Pharmaco-management of inhalation injuries for burn survivors. Drug Des Devel Ther (2009) 0.76
Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care. Biomed Res Int (2014) 0.75
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA (2013) 7.23
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49
American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71
Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A (2009) 2.66
Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One (2011) 2.58
Cytokine expression profile over time in severely burned pediatric patients. Shock (2006) 2.33
Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity (2004) 2.29
CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol (2004) 2.25
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med (2010) 2.22
Preclinical evaluation of epinephrine nebulization to reduce airway hyperemia and improve oxygenation after smoke inhalation injury. Crit Care Med (2011) 2.10
Long-term posttraumatic stress symptoms vary inversely with early opiate dosing in children recovering from serious burns: effects durable at 4 years. J Trauma Acute Care Surg (2014) 2.03
Impaired zinc and copper status in children with burn injuries: need to reassess nutritional requirements. Burns (2005) 1.98
Burn size determines the inflammatory and hypermetabolic response. Crit Care (2007) 1.97
A novel animal model of sepsis after acute lung injury in sheep. Crit Care Med (2002) 1.95
Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med (2008) 1.85
Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study. Crit Care Med (2013) 1.81
Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg (2010) 1.78
Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med (2007) 1.77
Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction. Crit Care Med (2006) 1.77
Synthesis of vitamin D in skin after burns. Lancet (2004) 1.75
Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med (2008) 1.73
Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab (2009) 1.71
Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med (2009) 1.68
Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med (2011) 1.68
Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med (2008) 1.67
Morbidity and survival probability in burn patients in modern burn care. Crit Care Med (2015) 1.67
Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med (2002) 1.66
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology (2005) 1.66
Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art? Crit Care Med (2005) 1.65
Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med (2007) 1.62
Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol (2005) 1.62
Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg (2004) 1.61
The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg (2006) 1.60
Influence of systemic inflammatory response syndrome on host resistance against bacterial infections. Crit Care Med (2004) 1.59
Serum cytokine differences in severely burned children with and without sepsis. Shock (2007) 1.59
The leading causes of death after burn injury in a single pediatric burn center. Crit Care (2009) 1.59
Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol (2003) 1.58
Benchmarking outcomes in the critically injured burn patient. Ann Surg (2014) 1.58
Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med (2002) 1.58
Prediction of mortality from catastrophic burns in children. Lancet (2003) 1.58
Hypoglycemia is associated with increased postburn morbidity and mortality in pediatric patients. Crit Care Med (2014) 1.58
Emerging infections in burns. Surg Infect (Larchmt) (2009) 1.57
Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury. Crit Care Med (2009) 1.57
Skin nitric oxide and its metabolites are increased in nonburned skin after thermal injuries. Shock (2004) 1.56
Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med (2007) 1.55
Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med (2010) 1.53
The effect of growth hormone on gut mucosal homeostasis and cellular mediators after severe trauma. J Surg Res (2005) 1.52
Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int (2004) 1.52
Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med (2006) 1.52
Body composition changes with time in pediatric burn patients. J Trauma (2006) 1.49
A genomic score prognostic of outcome in trauma patients. Mol Med (2009) 1.48
Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury. Crit Care Med (2011) 1.47
Inhaled nitric oxide reduces lung edema during fluid resuscitation in ovine acute lung injury. Intensive Care Med (2003) 1.47
Effects of balanced crystalloid vs. 0.9% saline-based vs. balanced 6% tetrastarch infusion on renal function and tubular integrity in ovine endotoxemic shock. Crit Care Med (2011) 1.46
Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection. J Leukoc Biol (2009) 1.46
Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children. Crit Care Med (2010) 1.46
Cerebral response to norepinephrine compared with fluid resuscitation in ovine traumatic brain injury and systemic inflammation. Crit Care Med (2006) 1.45
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor. Crit Care Med (2012) 1.44
Whole-body hypothermia: another option in smoke inhalation management? Crit Care Med (2006) 1.43
IGF-I gene transfer effects on inflammatory elements present after thermal trauma. Am J Physiol Regul Integr Comp Physiol (2003) 1.43
The effect of hepatocyte growth factor on gut mucosal apoptosis and proliferation, and cellular mediators after severe trauma. Surgery (2005) 1.42
Beneficial effects of concomitant neuronal and inducible nitric oxide synthase inhibition in ovine burn and inhalation injury. Shock (2011) 1.42